These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30428847)

  • 21. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
    Kang M; Hollabaugh K; Pham V; Koletar SL; Wu K; Smurzynski M; Aberg JA
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):172-80. PubMed ID: 24694927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
    Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.
    Lacombe K; Gozlan J; Boyd A; Boelle PY; Bonnard P; Molina JM; Miailhes P; Lascoux-Combe C; Serfaty L; Zoulim F; Girard PM
    Antivir Ther; 2008; 13(5):705-13. PubMed ID: 18771054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
    Matthews GV; Seaberg EC; Avihingsanon A; Bowden S; Dore GJ; Lewin SR; Sasadeusz J; Revill PA; Littlejohn M; Hoy JF; Finlayson R; Ruxrungtham K; Saulynas M; Locarnini S; Thio CL
    Clin Infect Dis; 2013 May; 56(9):e87-94. PubMed ID: 23315316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.
    Antonucci G; Mazzotta F; Angeletti C; Girardi E; Puoti M; De Stefano G; Grossi P; Petrosillo N; Pagano G; Cassola G; Orani A; Sagnelli C; Armignacco O; Sagnelli E;
    BMC Res Notes; 2013 Apr; 6():153. PubMed ID: 23594964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.
    Price H; Dunn D; Pillay D; Bani-Sadr F; de Vries-Sluijs T; Jain MK; Kuzushita N; Mauss S; Núñez M; Nüesch R; Peters M; Reiberger T; Stephan C; Tan L; Gilson R
    PLoS One; 2013; 8(7):e68152. PubMed ID: 23874527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
    Huang YS; Chang SY; Sheng WH; Sun HY; Lee KY; Chuang YC; Su YC; Liu WC; Hung CC; Chang SC
    PLoS One; 2016; 11(12):e0169228. PubMed ID: 28033344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of the Hepatitis B Virus/HIV-Coinfected Patient.
    Sherman KE
    Top Antivir Med; 2015; 23(3):111-4. PubMed ID: 26518394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
    Siemieniuk RA; Foroutan F; Mirza R; Mah Ming J; Alexander PE; Agarwal A; Lesi O; Merglen A; Chang Y; Zhang Y; Mir H; Hepworth E; Lee Y; Zeraatkar D; Guyatt GH
    BMJ Open; 2017 Sep; 7(9):e019022. PubMed ID: 28893758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
    Peters MG; Andersen J; Lynch P; Liu T; Alston-Smith B; Brosgart CL; Jacobson JM; Johnson VA; Pollard RB; Rooney JF; Sherman KE; Swindells S; Polsky B;
    Hepatology; 2006 Nov; 44(5):1110-6. PubMed ID: 17058225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
    Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.
    Choe WH; Kwon SY; Kim BK; Ko SY; Yeon JE; Byun KS; Kim GH; Lee CH
    Liver Int; 2008 Jul; 28(6):814-20. PubMed ID: 18312291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
    Luo A; Jiang X; Ren H
    Virol J; 2018 Sep; 15(1):139. PubMed ID: 30201035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.
    Aurpibul L; Lumbiganon P; Hansudewechakul R; Kanjanavanit S; Bunupuradah T; Kosalaraksa P; Taeprasert P; Puthanakit T
    Pediatr Infect Dis J; 2017 Apr; 36(4):401-404. PubMed ID: 28005687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.
    Park JH; Jung SW; Park NH; Park BR; Kim MH; Kim CJ; Lee BU; Jeong ID; Kim BG; Bang SJ; Shin JW
    Clin Ther; 2015 Jul; 37(7):1433-42. PubMed ID: 25956353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.
    Corsa AC; Liu Y; Flaherty JF; Mitchell B; Fung SK; Gane E; Miller MD; Kitrinos KM
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment algorithm for chronic hepatitis B in HIV-infected patients.
    Benhamou Y
    J Hepatol; 2006; 44(1 Suppl):S90-4. PubMed ID: 16352368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.